A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Journal: Nature Medicine Published: 07 April 2024 Title: Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial DOI: 10.1038/s41591‑024‑02894‑y Authors: Mark Yarchoan, Edward J. Gane, Thomas U. Marron, et al. What This…
-
Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and GLP-1 receptor agonist peptides
Applicant / Assignee: Pfizer Inc. Patent Application (PCT): PCT/IB2025/050625 Publication Number: WO/2025/158284 Filing Date: January 22, 2025 Publication Date: July 31, 2025 Inventors (examples): Robert Gregory Dullea; Kevin James Filipski; others What It Covers This…
-
Conjugates Comprising Transferrin Receptor Binding Protein
Patent Application (International / PCT): PCT/US2025/013955Publication Number: WO/2025/166111Filing Date: January 31, 2025Publication Date: August 7, 2025Applicant / Assignee: Eli Lilly and CompanyInventors (examples): Riazul Alam, Guillermo S. Cortez, Yan Wang (et al.) What This Patent…
